Literature DB >> 8940391

Increased susceptibility of islets from diabetes-prone Psammomys obesus to the deleterious effects of chronic glucose exposure.

D J Gross1, G Leibowitz, E Cerasi, N Kaiser.   

Abstract

Patients with noninsulin-dependent diabetes (NIDDM) show an increase in the relative plasma levels of proinsulin and proinsulin conversion intermediates, which is corrected by strict glycemic control. This observation suggests that hyperglycemia per se may be responsible for generating the aberrant plasma hormone profile. The question remains, however, whether a genetic predisposition to NIDDM underlies the failure of the insulin production machinery to meet a prolonged increase in secretory demand. In this study, islet monolayer cultures from the diabetes-prone Psammomys obesus and normal diabetes-resistant rats were exposed to RPMI 1640 medium containing either 11.1 or 33.3 mM glucose; insulin-related peptides were resolved by HPLC. Prolonged exposure (10 days) of rat islets to high glucose resulted in a reduced a secretory response to an acute glucose stimulus associated with a 37% reduction in the insulin content but no change in the proinsulin/insulin ratio. When subjected to a similar protocol, islets from prediabetic Psammomys lost the insulin response to glucose; beta-cell insulin content was reduced by about 70%, and the proportion of proinsulin-related peptides increased from 18% to 38%. In the in vivo situation, pancreatic extracts from nonfasted diabetic Psammomys contained 36% proinsulin-related peptides in contrast to 15% in pancreatic extracts from nondiabetic animals. Thus, prolonged in vitro exposure of prediabetic Psammomys islets to high levels of glucose could reproduce the modified beta-cell secretory profiles observed in vivo in the diabetic animal. These results support the hypothesis that hyperproinsulinemia in NIDDM is secondary to the inability of beta-cells to meet a sustained increase in insulin demand, whereas individuals with normal beta-cells may meet such demand with an adequate output of mature insulin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940391     DOI: 10.1210/endo.137.12.8940391

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Characterization of the action of S 21403 (mitiglinide) on insulin secretion and biosynthesis in normal and diabetic beta-cells.

Authors:  Nurit Kaiser; Rafael Nesher; Andrei Oprescu; Suad Efendic; Erol Cerasi
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

2.  Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release.

Authors:  K Hostens; D Pavlovic; Y Zambre; Z Ling; C Van Schravendijk; D L Eizirik; D G Pipeleers
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

3.  Augmented beta cell loss and mitochondrial abnormalities in sucrose-fed GK rats.

Authors:  Hiroki Mizukami; Ryuichi Wada; Motoi Koyama; Teruko Takeo; Sechiko Suga; Makoto Wakui; Soroku Yagihashi
Journal:  Virchows Arch       Date:  2008-01-31       Impact factor: 4.064

4.  Pancreatic β-Cells Express the Fetal Islet Hormone Gastrin in Rodent and Human Diabetes.

Authors:  Tehila Dahan; Oren Ziv; Elad Horwitz; Hai Zemmour; Judith Lavi; Avital Swisa; Gil Leibowitz; Frances M Ashcroft; Peter In't Veld; Benjamin Glaser; Yuval Dor
Journal:  Diabetes       Date:  2016-11-18       Impact factor: 9.461

5.  Divergent genes in gerbils: prevalence, relation to GC-biased substitution, and phenotypic relevance.

Authors:  Yichen Dai; Rodrigo Pracana; Peter W H Holland
Journal:  BMC Evol Biol       Date:  2020-10-19       Impact factor: 3.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.